|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:RB1CC1-MMP16 (FusionGDB2 ID:72549) |
Fusion Gene Summary for RB1CC1-MMP16 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: RB1CC1-MMP16 | Fusion gene ID: 72549 | Hgene | Tgene | Gene symbol | RB1CC1 | MMP16 | Gene ID | 9821 | 4325 |
| Gene name | RB1 inducible coiled-coil 1 | matrix metallopeptidase 16 | |
| Synonyms | ATG17|CC1|FIP200|PPP1R131 | C8orf57|MMP-X2|MT-MMP2|MT-MMP3|MT3-MMP | |
| Cytomap | 8q11.23 | 8q21.3 | |
| Type of gene | protein-coding | protein-coding | |
| Description | RB1-inducible coiled-coil protein 1200 kDa FAK family kinase-interacting proteinFAK family kinase-interacting protein of 200 kDaphosphatase 1, regulatory subunit 131 | matrix metalloproteinase-16MMP-16MT-MMP 3MT3MMPMTMMP3Putative transmembrane protein C8orf57matrix metallopeptidase 16 (membrane-inserted)membrane-type matrix metalloproteinase 3membrane-type-3 matrix metalloproteinase | |
| Modification date | 20200327 | 20200313 | |
| UniProtAcc | . | P51512 | |
| Ensembl transtripts involved in fusion gene | ENST00000025008, ENST00000435644, ENST00000539297, ENST00000521611, | ENST00000544227, ENST00000286614, | |
| Fusion gene scores | * DoF score | 8 X 6 X 6=288 | 4 X 3 X 3=36 |
| # samples | 9 | 4 | |
| ** MAII score | log2(9/288*10)=-1.67807190511264 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(4/36*10)=0.15200309344505 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
| Context | PubMed: RB1CC1 [Title/Abstract] AND MMP16 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | RB1CC1(53596109)-MMP16(89086971), # samples:2 | ||
| Anticipated loss of major functional domain due to fusion event. | RB1CC1-MMP16 seems lost the major protein functional domain in Hgene partner, which is a tumor suppressor due to the frame-shifted ORF. RB1CC1-MMP16 seems lost the major protein functional domain in Tgene partner, which is a essential gene due to the frame-shifted ORF. RB1CC1-MMP16 seems lost the major protein functional domain in Tgene partner, which is a IUPHAR drug target due to the frame-shifted ORF. | ||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Tgene | MMP16 | GO:0006508 | proteolysis | 24970228 |
| Tgene | MMP16 | GO:0016485 | protein processing | 27229514 |
| Fusion gene breakpoints across RB1CC1 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene breakpoints across MMP16 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | PRAD | TCGA-FC-A4JI-01A | RB1CC1 | chr8 | 53596109 | - | MMP16 | chr8 | 89086971 | - |
Top |
Fusion Gene ORF analysis for RB1CC1-MMP16 |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 5CDS-5UTR | ENST00000025008 | ENST00000544227 | RB1CC1 | chr8 | 53596109 | - | MMP16 | chr8 | 89086971 | - |
| 5CDS-5UTR | ENST00000435644 | ENST00000544227 | RB1CC1 | chr8 | 53596109 | - | MMP16 | chr8 | 89086971 | - |
| 5CDS-5UTR | ENST00000539297 | ENST00000544227 | RB1CC1 | chr8 | 53596109 | - | MMP16 | chr8 | 89086971 | - |
| Frame-shift | ENST00000025008 | ENST00000286614 | RB1CC1 | chr8 | 53596109 | - | MMP16 | chr8 | 89086971 | - |
| Frame-shift | ENST00000435644 | ENST00000286614 | RB1CC1 | chr8 | 53596109 | - | MMP16 | chr8 | 89086971 | - |
| In-frame | ENST00000539297 | ENST00000286614 | RB1CC1 | chr8 | 53596109 | - | MMP16 | chr8 | 89086971 | - |
| intron-3CDS | ENST00000521611 | ENST00000286614 | RB1CC1 | chr8 | 53596109 | - | MMP16 | chr8 | 89086971 | - |
| intron-5UTR | ENST00000521611 | ENST00000544227 | RB1CC1 | chr8 | 53596109 | - | MMP16 | chr8 | 89086971 | - |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| ENST00000539297 | RB1CC1 | chr8 | 53596109 | - | ENST00000286614 | MMP16 | chr8 | 89086971 | - | 10562 | 369 | 0 | 1109 | 369 |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000539297 | ENST00000286614 | RB1CC1 | chr8 | 53596109 | - | MMP16 | chr8 | 89086971 | - | 9.79E-05 | 0.999902 |
Top |
Fusion Genomic Features for RB1CC1-MMP16 |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
 |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for RB1CC1-MMP16 |
| Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr8:53596109/chr8:89086971) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| . | MMP16 |
| FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. | FUNCTION: Endopeptidase that degrades various components of the extracellular matrix, such as collagen type III and fibronectin. Activates progelatinase A. Involved in the matrix remodeling of blood vessels. Isoform short cleaves fibronectin and also collagen type III, but at lower rate. It has no effect on type I, II, IV and V collagen. However, upon interaction with CSPG4, it may be involved in degradation and invasion of type I collagen by melanoma cells. {ECO:0000269|PubMed:11278606}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Tgene | MMP16 | chr8:53596109 | chr8:89086971 | ENST00000286614 | 5 | 10 | 389_434 | 361 | 608.0 | Repeat | Note=Hemopexin 2 | |
| Tgene | MMP16 | chr8:53596109 | chr8:89086971 | ENST00000286614 | 5 | 10 | 436_484 | 361 | 608.0 | Repeat | Note=Hemopexin 3 | |
| Tgene | MMP16 | chr8:53596109 | chr8:89086971 | ENST00000286614 | 5 | 10 | 485_532 | 361 | 608.0 | Repeat | Note=Hemopexin 4 | |
| Tgene | MMP16 | chr8:53596109 | chr8:89086971 | ENST00000286614 | 5 | 10 | 586_607 | 361 | 608.0 | Topological domain | Cytoplasmic | |
| Tgene | MMP16 | chr8:53596109 | chr8:89086971 | ENST00000286614 | 5 | 10 | 565_585 | 361 | 608.0 | Transmembrane | Helical |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | RB1CC1 | chr8:53596109 | chr8:89086971 | ENST00000025008 | - | 5 | 24 | 1438_1485 | 123 | 1595.0 | Coiled coil | Ontology_term=ECO:0000255 |
| Hgene | RB1CC1 | chr8:53596109 | chr8:89086971 | ENST00000025008 | - | 5 | 24 | 859_1397 | 123 | 1595.0 | Coiled coil | Ontology_term=ECO:0000255 |
| Hgene | RB1CC1 | chr8:53596109 | chr8:89086971 | ENST00000435644 | - | 5 | 24 | 1438_1485 | 123 | 1592.0 | Coiled coil | Ontology_term=ECO:0000255 |
| Hgene | RB1CC1 | chr8:53596109 | chr8:89086971 | ENST00000435644 | - | 5 | 24 | 859_1397 | 123 | 1592.0 | Coiled coil | Ontology_term=ECO:0000255 |
| Hgene | RB1CC1 | chr8:53596109 | chr8:89086971 | ENST00000539297 | - | 3 | 22 | 1438_1485 | 123 | 1592.0 | Coiled coil | Ontology_term=ECO:0000255 |
| Hgene | RB1CC1 | chr8:53596109 | chr8:89086971 | ENST00000539297 | - | 3 | 22 | 859_1397 | 123 | 1592.0 | Coiled coil | Ontology_term=ECO:0000255 |
| Hgene | RB1CC1 | chr8:53596109 | chr8:89086971 | ENST00000025008 | - | 5 | 24 | 663_666 | 123 | 1595.0 | Compositional bias | Note=Poly-Thr |
| Hgene | RB1CC1 | chr8:53596109 | chr8:89086971 | ENST00000435644 | - | 5 | 24 | 663_666 | 123 | 1592.0 | Compositional bias | Note=Poly-Thr |
| Hgene | RB1CC1 | chr8:53596109 | chr8:89086971 | ENST00000539297 | - | 3 | 22 | 663_666 | 123 | 1592.0 | Compositional bias | Note=Poly-Thr |
| Hgene | RB1CC1 | chr8:53596109 | chr8:89086971 | ENST00000025008 | - | 5 | 24 | 566_569 | 123 | 1595.0 | Motif | Nuclear localization signal |
| Hgene | RB1CC1 | chr8:53596109 | chr8:89086971 | ENST00000435644 | - | 5 | 24 | 566_569 | 123 | 1592.0 | Motif | Nuclear localization signal |
| Hgene | RB1CC1 | chr8:53596109 | chr8:89086971 | ENST00000539297 | - | 3 | 22 | 566_569 | 123 | 1592.0 | Motif | Nuclear localization signal |
| Tgene | MMP16 | chr8:53596109 | chr8:89086971 | ENST00000286614 | 5 | 10 | 99_106 | 361 | 608.0 | Motif | Cysteine switch | |
| Tgene | MMP16 | chr8:53596109 | chr8:89086971 | ENST00000286614 | 5 | 10 | 340_388 | 361 | 608.0 | Repeat | Note=Hemopexin 1 | |
| Tgene | MMP16 | chr8:53596109 | chr8:89086971 | ENST00000286614 | 5 | 10 | 120_564 | 361 | 608.0 | Topological domain | Extracellular |
Top |
Fusion Gene Sequence for RB1CC1-MMP16 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >72549_72549_1_RB1CC1-MMP16_RB1CC1_chr8_53596109_ENST00000539297_MMP16_chr8_89086971_ENST00000286614_length(transcript)=10562nt_BP=369nt ATGAAGTTATATGTATTTCTGGTTAACACTGGAACTACTCTAACATTTGACACTGAACTTACAGTGCAAACTGTGGCAGACCTTAAGCAT GCCATTCAAAGCAAATACAAGATTGCTATTCAACACCAGGTGCTGGTGGTCAATGGAGGAGAATGCATGGCTGCAGATCGAAGAGTGTGT ACCTACAGTGCTGGGACGGATACAAATCCAATTTTTCTTTTTAACAAAGAAATGATCTTATGTGATCGTCCACCTGCTATTCCTAAAACT ACCTTTTCGACAGAAAATGACATGGAAATAAAAGTTGAAGAATCTCTTATGATGCCTGCAGTTTTTCATACTGTTGCTTCAAGGACACAG CTTGCATTGGACCAGTGGTTTTGGCGAGTGAGAAACAACAGGGTGATGGATGGATACCCAATGCAAATTACTTACTTCTGGCGGGGCTTG CCTCCTAGTATCGATGCAGTTTATGAAAATAGCGACGGGAATTTTGTGTTCTTTAAAGGTAACAAATATTGGGTGTTCAAGGATACAACT CTTCAACCTGGTTACCCTCATGACTTGATAACCCTTGGAAGTGGAATTCCCCCTCATGGTATTGATTCAGCCATTTGGTGGGAGGACGTC GGGAAAACCTATTTCTTCAAGGGAGACAGATATTGGAGATATAGTGAAGAAATGAAAACAATGGACCCTGGCTATCCCAAGCCAATCACA GTCTGGAAAGGGATCCCTGAATCTCCTCAGGGAGCATTTGTACACAAAGAAAATGGCTTTACGTATTTCTACAAAGGAAAGGAGTATTGG AAATTCAACAACCAGATACTCAAGGTAGAACCTGGATATCCAAGATCCATCCTCAAGGATTTTATGGGCTGTGATGGACCAACAGACAGA GTTAAAGAAGGACACAGCCCACCAGATGATGTAGACATTGTCATCAAACTGGACAACACAGCCAGCACTGTGAAAGCCATAGCTATTGTC ATTCCCTGCATCTTGGCCTTATGCCTCCTTGTATTGGTTTACACTGTGTTCCAGTTCAAGAGGAAAGGAACACCCCGCCACATACTGTAC TGTAAACGCTCTATGCAAGAGTGGGTGTGATGTAGGGTTTTTTCTTCTTTCTTTCTTTTGCAGGAGTTTGTGGTAACTTGAGATTCAAGA CAAGAGCTGTTATGCTGTTTCCTAGCTAGGAGCAGGCTTGTGGCAGCCTGATTCGGGGCTGACCTTTCAAACCCAGAGGGTTGCTGGTCC TGCACATGAGTGGAAATACACTCATGGGGAAGCTTCCATGATGCACAGTATCTGCTGTTCTTCAGTCCTTTGTCTTTCTTTGTCATTCAG TTCTAGGCCTTTCCTCTGCACGCTCAATGCCCAGTAAAATTTCAGGATTAACTAAAGAAGAGGAGAAAAAGAAGAAAAGATTCTTCTTAA AAGTTTCTAATGTTATTTTCCTTCTGAAGTCTGAGCCCATTTCTGGGGGGAGAAAAAAAAAGCAAATCAGAAAACCCACGGTTTTTCTTT TTTTCTTTTTTTCTTTTTTTCTTTTTTTGCTTTAAAACAAAGGGAAAAAAGAGTTTAAACAAAAAACCCACAATTGAACTTCCAGGAAAG TGTGAAGACCCAAAACAGCTTTGTCTCCAAAGAAGATAGCTCTCTGACTGCTTTGGATAGTCTCCTACGCACCATTTTGTCAGGTGGGAG ATTTGGAATACACATGCAGGACGTTAGACTGTTGGGACAGCCATTTTCCAACAACCAAGGGGCCAAAATATCTGCAATATAGTAACAGCC TTAATAATACATCCATTTTTCGTTTTATACAGCTGTTCTCAGCTATGTCCTCAGTGTTTCATCGCATTTATATTCATAGCTATTTTCAAA CACGACCTTTTAATTGTTTTTGAAGTATTTCTAAACCCCTTCTTTCCACCTTACTCCTCCATCATTGTGATAATCTTCCCAAGTTGTATT AGGCCATTGCCCCAGGCCTTCCATGGGTCTGTCAGGAATATTCGTTACAAAGCAGAGCAAGAAGCAGTATGTCTCTGAAGTGGATTACAG TGGCAGTTATTTTACAAGGATTTGTGACACTAGTAACATACCCGTGTAACCCTTTGAGAACTATCAGACCAGCTTTCAGAGTCTTAGGAT TGTCGGTCTTGCGATCTGATAAATTATAGAACTGGGCAATGGTAAAAACAGTCACAAGTTCAAGAAGTTCAGGTTTTTAAAACAGATATC CTATAATGTCATATAATTTTTAAATGATTTACAAGACTACATAAATGTGTTTATAACAAACAGAAATGATGTTACTTGCCAAAATTTTTC TGGCAAATAAAAAAGGTATTTTATTAAGATTCTCATAAATCTGAAATTTTATTTGAAAAACTGATAATAGCCTAAGTCTTCTTTTCTTTT TTTTAGGCATACTGAATTTCTGTTTTAAAATCCATTGCATGAAAATTCAATTTGCCTTGGTATATGCAGTTAGCATTGCCATTTTAAAAA TGAATTAAAACGGTGACTCTGAAGTTGCATGAATATCCTCCAGTGCATTACCTATTGCATGTCCACCATAGTTCTCAAAGGGTTAGTGTG GCTTCTGGCATTTAGCCGTCCATTTGATCACTGACAGAGCCAAGAGACCACCAAAGCATTTCATTGTTGAGTGTAATTTGTCCTAACAGC AGTATTGTCATTTTCATGTGACCTGCAGAGCAGGTTTGTATCAATATTTTTTTCCTAGAGAAAAGTCAGCAACTGACAGACCTCTTTATT GATTTTTAGGAGCTGCTTCTTGCAGTGAAAGGCTTTACAGCCACTGGGCTGTGAACTTATTAGAGATGGTCAGAATGAATGCACCCCATG AGTCAGACATTGGCTTTGTGTGAAAGCCAGCTTTGAGGGGATTAGCTTTTGAAACAATGAACAGCTTGCCTTGAACTTGATTATTGATCT ATTGACTGTCATTAACAACAACTTAAACATTGTCTTCTGTGAAAATTTTCCTTGAAGAGTCCTGTTCTATGTCTTTGCCCTTTGACCTTT AACTTGCAAACTGGCACAAACTGAAGGAAATCTGGTGTTGCTTCTCCATTGGATTAGTTGTTCTCTAAAACCTAGTAAGCATGAGCTGTT TCCTTAGAGTGGAGAGAGTGGTGATGGCAGATCTGCAGATGGACACTTTGCTCTTTACATGCACACTCTGAAAATGCCCTATAGGTAGAA GTGAATTTTAATTTCATTTTAATATAATTTCAAGTCTAAATTCATCATTTTAGTACAAATTACAAAAACTATAGGAAAAAAAAAACCTCA AATACTTGAATGGCCAGTGTGGCTTTTATATAAAGCAGGAATTTTATACTAGTAAAAATTTCTTACTCATTTGCTAATACACATTTCCAG ATGATTTTTAATGAGTGTAGGTATACATTCTTATTTGGAAATGGATAGTTTGGCTGCCTTGAATTTATATTTATACTCAACGTAGCATGA AAATTAGAATGCCTTTTGGTTAAACTACATGTTTATGATTTGGTTGGGGAAAATATTTTATAATTGTGGGTGGCATGCTGCAAAGCCTTG CAGATTGTTATTTCTTACAACCTGAGCGTATATAGTATGAGCCTAAGAAAAAAGAAGAGTAAGAAAAGAAGAATGGCTTTACAGTAAAAT ATCATACAATGCAGACAATATTTTAAGAGGATATTGGAGATTATGTACGCAAGGGCCAAGAAAGCAAGAAATGAGAACCAGAGTCAGCCC TGTAGCTTTACTTCAGTGCTTCCATTCTAGATGATGCTGATATTATAAAGAGTTAGTCACTGCTGCTAAGCATGGAGGACTATATACATA AGCTCGTTTATACAGTGTTTGCTTGTGGGAGGGTTTAATCCTTTTAGGGCCTTGATGTCAAGAAAAAAATAACTGGAAACTATATTTTGC TAAAGATAGAAATGAGGAACTGTGTCATTTTGGGACATGTGCAAATCATTGAGGAACTCCATCACCCTGCATTGAAAATTGATTTTTTTT TCCTCTAAAATGAGAAAGAAACTGAATAAGCAATCTGTTGCCTCTTTACTCATTCATCACAATATCCTGATTCGTCATAAGGCTATCAGT ATATAAGGGCTAGAAAATAATCATAGCATTAAGAAGGAAGGAGTCTATCATTATGCTTGAATTCTGGCAAATGTCATGAATAAGGGTTGG GTCATATTTACTTTAATATGAGACAAGATTTATGTGATAAGCAAAGGCATATAAGGCTGCTCTTTTGAACAGAACATTTCAGTTATCAGG CTGTACTATTACAAGAGATAAGAAGACAATAAGGACAATGTAATCACAAACAGTGGGATTCCATTTGTTTATTGTACACCAGCTACTTTG TGGGTATGGTTCCTGACTCCTCTTCTACATGAGGTTTGGGAAAAAAGTCTCAAACCAAATGGAACAGTGAAAGGGAAAGTAATTCATCTA GCACATAAGAATAGTGATTCAAAACCAATGCAGAATAAATTTCCATGGGTCAATAACATAAGGTGTCAGTTCAGTGTTACTAGAGATATG CAAGGCATAAAATATTTTCATCACCCCATCACTAATAACATGAAAAGCTCAGACATAGGATTTCCCAAATTGAAATGAAAACACATTCAT GCCTGCAAAAATAATTCTCCTTCTGCTTCATTTCTCATTACTTTATCTAATATAAACACAAATGTAAACAAGGTAATGGTCTTCATGTAA AATGACCATATAGTTAAGAATTTTAGTAAAATATTGTTGTTCTGTGTATTATTAAACAAATGCAATGAAGTATTAAAATAGCTGATCAGT TTGAATTTCCTGTAAAGCAGTAATTCCGCATCAGAATTGTAGATAAGGTTGTGAATTTATTGACTCATTTCAGAACAGTGTCTGTTGACA TGGCAGTCAGAGCAGGTGAATACAGATGCTCTTTCTGATTGCAAAGGTTATAGAGCTAAATTAGACAGCATTATGTGATACTAGCAAAGA CAACTTCTGTTATAAATCAGAGGGCAAGGCTTTTCTGAATCGATGTGATAAATTACTAAGTAATGATTACCAAAAATAATTACTAAGTAA TAAAAGATACAGACTGGTTTACTGAAATAAGCAAGTGTTACATTTAATAATTACCTATAATCTTTTTTTGTTAACACATAAGCAAGTGTT ACCTTTAATAATTACCTATAATCTTTTTTTGTTAACACATAATTTGGCCATTTCATATACTGTGTACCTATTTTCATTCCCTCTCTGTGG GTCATTAAAAAACACAATGTGGTGGATAAGAACATTGTCCAAACTTCACTGCTAGTTCCAATACATAGATGATGGTGTGTAAACTGGATT GTAGGGGTAGTCATATTTGCAAGTTCTACATGTTATGCTAATATATCTAGTATGGTACACATACACGCCCACACTTTGTGGATCTTACAG TGGAATAAATAGTGTGTCCATATTAACTAAACTCAAAGTGCTATCTGAAGAGGAATGGATGTTATAAGCAGACAGACAGACTGAGTTAAA CTGAGTCATGAAAAAATATATATTTTAAAGTTTTTGGAATCATTTCCAGAAACTAATAAAGGGAATTATTTACTGGTAGTATTGAGTCTG TGAGATTGTAGTATATACTGAAACAATCTTCTGGATGGTGGTAAGGTCTTTTTTAGCAAACACAGTAAAGAGCTTATTTCATTTCTGATG CTTTCAAGGGCATATTCCAAAGTATCACAGATGTCAAATAGAATATGCTATATAAACCAAAAATGTGCATTTCAGATGACCTATTACAGC AATCTCAGCCAATATGTAATATCACAAAATGTGTCAAGTCAATCATATAAGAGGATCTAATCATTCGGCTGTATTTCATGTACCTTCATG TTGTTGATATATTGTGACCACAGGAAATAGGTGCCAGAGCATATGCAGTTAAGTTACAGGCTCCACGTTGCCTAGGAGGGAATCATAACT ACATCAGAAAATTTTTAACAGTTATATCTTAAAAATTAGAATTTTATGTAATAAATAAAGCGGCAACCAGGAATAGCAACGCAACAAATA TGAAAGCTAATTATTATATTTAGCTTTCATATTTATATAATATGATGGAAATGGAGGAGGAAAAATGAGTCTTTTGTTAAATATAAAGAC AAACTATAACACTCCTTGATAATACAACTGGAAATTTTACTTTAGCAAGCATAAAATAGTGGAGGAAAAAAATCCAACTTCAAGCTCTTT GCACTAGTGATGATTATGTGATATATCAATGTAATATTTAGCCAGTGGTCATTAGATGTTACTGTGCTTAAACACATCTGATACTCATGC ATTGCCTTACAGGCTAAAAATGTAAGAGGTAGGTGTTCAGTAACCTCAAGTTGGAAAGATATATAATGTTAGAATCCCCTGAGACAAGCC ATTTCCCTGAAATAGAAATTTACCTCAATACTCATGTAATCTAAGACACTTGGCGTAGTAGCAAAGAAGTTGCCTTCATGTTCTAGTCTC ATCTAATTGTGACCTTTGTCTTTCATGTACTTCTGAAATCATTTTCCACTTTTTCCACTGGTGTGATTTTGAAACAATTCTGAAATATTT CAGGTAAGATTAATAACATCCAATTACAAATATATGTTTCAATATTTTATACGTATGTCTACTTTGAAAGTTAAACCAATAGTATAGAAA GCCTAAGAATGAACACTGATTGGACATACTCACAGAAATTAAGGGAAAAACACATATTGTAAAATTCCTGTCAATGTTTGAGTAGAATAC AGAAGTACATAGCAGTCTTCAATTTTTAAACACAATTATGGGCTTATAACTGGACGTGACATGCATCATTTATTAGAACAATATTATTTA TTTATACTAAGTAAGGATATAAGATCACAGAAGCTTAGTGTTATAACGGAGACTTCACAGACATTCATAACTAATGTTTTCTAAGGCAAA TAAGGGCATAAACCAGAACTCATGGTCAGTGCAGAGTAAGTATAAAAAGTTATGTATGAAAGACATTTATTTATAGAGATTTCTGAGGAT TCTATGCCTTTTCAACTTAAAGATGAGTGTGTCTTAGAATTTGTTTTATGCATCATTGGACTGGGGATGATATTCAAATGTGCACTCAGC GTGTCCTCACATTAAAGGGCACATTGAACAGTATAGGAAAATACATCATAAACTAGAATGTTGTACAGATTCATATAACTTTCCCATGTG CTCTGCTGTAGAGCTGAATTTATATGCCCTTAAAAAGGGATAAGAATCAATTAAATATAAATACGGAAATATACTTATGTTAGGTCACTT AGCTTCAGAGCAAGATGTCATTAACCTTTATTTCACAGAGAAAAACTGGAAGAAAAGAATGGTGAACAAGAATAAAATGATAAACTTTTT GGCTTATAGAGATGTTTCTTGGGAATTTTTTCCACTTGTTTTTATACATGAAAAAAATATCAGTCACAATACAGACATTTCTGTAGTATT TGGTCTGTGGGTAAACTGGATCCCAGGCAGAATACTTTTTGACACAGGCCTTTTTATACATGCTTTATATATGATGAAGCTTTGGTGAGA TGTGACTGCATGGTAGGATGCATTTTCCTAGGATAGGATATGGTGCTGCTTGTACTTGCCACCTTTTATATGAATGTATGTCGCTACATT GGCCTGTCTTGCCAAGACATGGTTGAATGAAGCCTGGTGTGAGCTGTCTATTTGAAAAGTCACTAGGATGCATGTTTCATTTGCCGTTAC ATAATGCCAATTTGAACCTGTTTCCTCTATATATTAACAATCCAATTGTTAAGATAAAATATACTTTGCTTGAATGAATGATTTTGGTAG TAATATGAGCGTTATCCTTAAATCAATGTTACAATTTTTGCTATTACTGAAATACCGTCACAGAGGCCACATTATTGGCTGTCTATACCA TTGCCTGAGTAAAATTAGGTTTTTAGGTCTTTTTGGCATTTACTTCTTTTACAGCTGATGTGGAATCAATTATTCCTTTATATGTTCATA AGTACAAAATTTCACTATCTTAATTACTTCCAAACAAACAATTTCCAAGCAAGGGTATGTGTGCCTGGTTTTTCTGCTCCTCCAATTCTA AGATCGTTATTTGTTTGCCTTCTGTTTCTCACCCAAAAATACAGATGGTTGGGAAAGATACATCTTATTGAGTTGTCCTATGCAGTCTCT GTCTATATTTGCATTTCTTTCTATTCCTATCTTGCCTTTTTTTTTTTTTTTTACACAGATTTGGTTTTCCCTTCCCTTTGTGAAAACCAG AATTGAGCAGCATTGTACATCAGAGATGGTACCCAGGAAATGTCTTTGTTCCTCAGTATTTTTCGTCAAAACTTCCATGCAAAGACAGTC CCAGCAAAGTTGACATACATCCCAACCTCTCTCATTGGCTTTTCTAACTTTTTATAGAGCTATTCCCCTGAGAAAAGTGAAATGCTGAGT ATGATGGGTATTGCCTGTTGATAGGATAGCTAAGGAAATTTGCTTTTGGAGAATGTATCTTAAATAATTATACAGGAAAGTAGTCACAGT ATAGTGTTCTGTTTAAGGTACATCATGGGTACATAAATGCCTAAAACCTTCATCCTTTGGTCTATTTCTCTGTAAGTGTAAATTACATAT ATATTAGAAAGAGAGATAGAATCAAAGAATTAGGGGTGTTACAGAGGCAGCTTTTTGCTGCCTTGGTTTTGACTGTATCAGCATTTCTAT TGCAGACCTCTATTTTCAGGGGTTTTAGAGACTCGACCATAAAAATTTGTTTCAGGCTTAAAAGTTTTGAAAGATTTTTTTAGGTATCTG ATTTTAAACAAATAGATCTTGTTTTTATATTATAGGAGGGAAATAAATGGAGTTTACTAGTTCAATTTTGCGCTAATATAACTTTTAATA AACTTAACTTTTTAAACAAAAACATAAAATCTAATTAGTTCATAGTTGGTTGATGCTTTTTTAAAAGAATCAATTATTGACCTTGAGAAA CTTGCCTGCTTCATCAGTATAGTAACCTATCTTTAAGATATTTTAAAACGTGTATACCTTTATTAACATTATCTTGATTCCAGCGGTGGA TCAGTATGATAATGCAGATTTATGACATCCATATAAGCTATCTGGTAATATAGATTTAGGAATATATAGTATATATGATACATATATATA TATATATTTACTAGATAGATTAAGGAGAAAAAGCTCCCATAAACTTAGTTTGTCAAATAAATACCATATATTTAAAAAATGCACAGACAT TTATCATTCAGAGTCAGAATGAGATTCAAGTAATTGCAAAGGGAAGTTGTCTCTTGGGTAAACAATACACATTTTATAGCTTCTTGTGAA ACTAATTTTTTCCTTTCTATATTGTGGTTATGGGAAAGTAAAAGAATTAAAATTAATACAGACTTTATTTAAATAACATTAAACTGTGAA GCAGAGAGAAACGCCAGGAAATTAAATATTTAGGCCATTATCTTGTGGTTGTCTGACAATACTTCACCTTTCTTTTAATTCCCCATGATG TTTTCAATTATGGAGAGAGTATTAAAATCTAGATTTAAGTTTCTGCATTGTTCTCATTACACTCAACACTATTTCATTAAGTTCTTGATA ATATGTAGTCTTCTGTGTGCAAGGAAAGAAATAAATAACACATTTATTTGCTGAATGAGTTTTAAGGTGTGCAAGTTGTAGTGATGTTTT TCCCACACAGGATTCTATACACTTATACCATCTTAAATCTGGCATTTTTTTTTTCAGATAGCTTCTACTGACAAACACAAAGCTTGTTTG TGTGCAAATATAAGGCTAAATAAATGGTGCTAAAGTGTATTATGACTGTCAGATAAAATCAGGCAAAATTTTGTGGTGCTTAAATTAATT TTTTCATTGATTTTATTGATCAGTGCATTGAACAGTGTTTATTATTCACAAGTTGTCTTTTATTAGTAAATCAAGGCCTCATAGCACATT GTTAAATAAAGTGGTTGACTAGTCTATGTAACAGCTCACCAAGCTACTATCTCTTTTAACTCCTTATAATGTTGCGTCATTAAAGGTCAA GGGGTCATGCTATTAATCTCATTGCTATAGACCATTAACATGACTGAACTTTTCCACAAAGTACTTATGTTTACAATGCTATAACCCTTT GACTGCTGCGGCAACCTTTAACCACACAAATGTCACAAGCTAGAATCATCAGCATGGTTCTTGCCATGGCAATCAAAGAGTTAAGGGCTG TGCAGTGATTTGTTTTGTATTTATTAATTTATATTTATTTTGTTTCCATTCAAGGAGGGGATTAGGGGTGGGGCAGTTTTTGTCTGCTGT AAGTGTCTTAACCTAGGGAAGGGTTAAATGGCTTTTTATACTATTGCATCTTCTGTATTTACCATCAATTCATTGTGTTGTAATTAAAAG >72549_72549_1_RB1CC1-MMP16_RB1CC1_chr8_53596109_ENST00000539297_MMP16_chr8_89086971_ENST00000286614_length(amino acids)=369AA_BP=123 MKLYVFLVNTGTTLTFDTELTVQTVADLKHAIQSKYKIAIQHQVLVVNGGECMAADRRVCTYSAGTDTNPIFLFNKEMILCDRPPAIPKT TFSTENDMEIKVEESLMMPAVFHTVASRTQLALDQWFWRVRNNRVMDGYPMQITYFWRGLPPSIDAVYENSDGNFVFFKGNKYWVFKDTT LQPGYPHDLITLGSGIPPHGIDSAIWWEDVGKTYFFKGDRYWRYSEEMKTMDPGYPKPITVWKGIPESPQGAFVHKENGFTYFYKGKEYW KFNNQILKVEPGYPRSILKDFMGCDGPTDRVKEGHSPPDDVDIVIKLDNTASTVKAIAIVIPCILALCLLVLVYTVFQFKRKGTPRHILY -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for RB1CC1-MMP16 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for RB1CC1-MMP16 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for RB1CC1-MMP16 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies